105 results
Page 5 of 6
424B3
kk440g0 7k0
10 Apr 15
Prospectus supplement
12:00am
10-K
fby bqy74mopl87
25 Mar 15
Annual report
12:00am
424B3
355xnrp
26 Feb 15
Prospectus supplement
12:00am
8-K
EX-99.1
f35pownw5qztg uvi
5 Feb 15
Recro Pharma to Present at the 17th Annual BIO CEO & Investor
12:00am
8-K
EX-99.1
4c4l10htre3v0s7
3 Feb 15
Recro Pharma Enters into Common Stock Purchase Agreement with Aspire Capital
12:00am
8-K
50mou2k 3nakz
19 Dec 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
mpkv1w44
10 Nov 14
Recro Pharma Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.2
f0m10t 5u
10 Nov 14
Recro Pharma Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
hfa893uwnopbngwo77
30 Oct 14
Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery
12:00am
8-K
EX-99.1
m71h68m gzi
9 Sep 14
Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference
12:00am
8-K
EX-99.2
tau93ya yf3ej
9 Sep 14
Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference
12:00am
8-K
m0bu2f58 te
4 Sep 14
Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN
12:00am
8-K
EX-99.1
iq2ky06
4 Sep 14
Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN
12:00am
8-K
EX-99.1
4rqct2mu4ad9c
12 Aug 14
Recro Pharma Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
sptgp0bf 12mfpt
1 Jul 14
Other Events
12:00am
8-K
EX-99.1
5zybm uapel0h04f
17 Jun 14
Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery
12:00am
8-K
EX-99.1
aidzb
1 Apr 14
This presentation includes forward-looking statements within the meaning of Section
12:00am
8-K
EX-99.1
8cbbxgn7
13 Mar 14
Recro Pharma Announces New Board Members
12:00am